Evidence map›Paper›PMID 31636302›Full record

ArticleScientific data2019

The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system.

Adriana Tomic, Ivan Tomic, Cornelia L Dekker, Holden T Maecker, Mark M Davis

Abstract readDataset
In one paragraph

Article in Scientific data, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Aging restricts maturation of CXCL13bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mucosal vaccines - fortifying the frontiers.Nature reviews. Immunology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. A robust and interpretable end-to-end deep learning model for cytometry data.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adriana TomicInstitute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. info@adrianatomic.com.ORCID http://orcid.org/0000-0001-9885-3535
Ivan TomicIndependent Researcher, Stanford, USA.
Cornelia L DekkerDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94304, USA.
Holden T MaeckerHuman Immune Monitoring Center, Stanford University, Stanford, CA, 94304, USA.
Mark M DavisInstitute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94304, USA. mmdavis@stanford.edu.

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Stanford Center for Clinical and Translational Education and Research (SCCTER)UL1UL1RR025744 · NCRR · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2008 to 2011
$22.4M
Vaccination and infection: indicators of immunological health and responsivenessU19AI090019 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 2010 to 2015
$17.3M
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) FluPRINT, No 796636Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR003142NCRR NIH HHS UL1 RR025744NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI090019
6 · The paper itself

Abstract

Machine learning has the potential to identify novel biological factors underlying successful antibody responses to influenza vaccines. The first attempts have revealed a high level of complexity in establishing influenza immunity, and many different cellular and molecular components are involved. Of note is that the previously identified correlates of protection fail to account for the majority of individual responses across different age groups and influenza seasons. Challenges remain from the small sample sizes in most studies and from often limited data sets, such as transcriptomic data. Here we report the creation of a unified database, FluPRINT, to enable large-scale studies exploring the cellular and molecular underpinnings of successful antibody responses to influenza vaccines. Over 3,000 parameters were considered, including serological responses to influenza strains, serum cytokines, cell phenotypes, and cytokine stimulations. FluPRINT, facilitates the application of machine learning algorithms for data mining. The data are publicly available and represent a resource to uncover new markers and mechanisms that are important for influenza vaccine immunogenicity.

Indexed as

Immune SystemImmunogenicity, VaccineMachine LearningAdolescentAdultAgedAged, 80 and overAntibody FormationChildChild, PreschoolCytokinesFemaleHemagglutination Inhibition TestsHumansImmunophenotypingInfantCytokinesInfluenza Vaccines

Identifiers

PMID31636302
PMCPMC6803714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.